Cargando…

Signatures of V(H)1-69-derived hepatitis C virus neutralizing antibody precursors defined by binding to envelope glycoproteins

An effective preventive vaccine for hepatitis C virus (HCV) remains a major unmet need. Antigenic region 3 (AR3) on the E1E2 envelope glycoprotein complex overlaps with the CD81 receptor binding site and represents an important epitope for broadly neutralizing antibodies (bNAbs) and is therefore imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Capella-Pujol, Joan, de Gast, Marlon, Radić, Laura, Zon, Ian, Chumbe, Ana, Koekkoek, Sylvie, Olijhoek, Wouter, Schinkel, Janke, van Gils, Marit J., Sanders, Rogier W., Sliepen, Kwinten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328973/ https://www.ncbi.nlm.nih.gov/pubmed/37419906 http://dx.doi.org/10.1038/s41467-023-39690-0

Ejemplares similares

Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate
por: Sliepen, Kwinten, et al.
Publicado: (2022)

Optimized cell systems for the investigation of hepatitis C virus E1E2 glycoproteins
por: Kalemera, Mphatso D., et al.
Publicado: (2020)

Engineering and Characterization of a Fluorescent Native-Like HIV-1 Envelope Glycoprotein Trimer
por: Sliepen, Kwinten, et al.
Publicado: (2015)

Enhanced Immunogenicity of HIV-1 Envelope gp140 Proteins Fused to APRIL
por: Isik, Gözde, et al.
Publicado: (2014)

Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses
por: Radić, Laura, et al.
Publicado: (2023)

Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCV
por: Marín, María Q., et al.
Publicado: (2020)

Profound structural conservation of chemically cross-linked HIV-1 envelope glycoprotein experimental vaccine antigens
por: Martin, Gregory M., et al.
Publicado: (2023)

HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity
por: van den Kerkhof, Tom L G M, et al.
Publicado: (2013)

Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics
por: Torrents de la Peña, Alba, et al.
Publicado: (2019)

HIV-1 Envelope Glycoprotein Resistance to Monoclonal Antibody 2G12 Is Subject-Specific and Context-Dependent in Macaques and Humans
por: Malherbe, Delphine C., et al.
Publicado: (2013)

Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity
por: Sliepen, Kwinten, et al.
Publicado: (2015)

Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies
por: Brinkkemper, Mitch, et al.
Publicado: (2019)

Biochemical evidence linking the GIX thymocyte surface antigen to the gp69/71 envelope glycoprotein of murine leukemia virus
Publicado: (1975)

A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike
por: Claireaux, Mathieu, et al.
Publicado: (2022)

Stabilization of the gp120 V3 loop through hydrophobic interactions reduces the immunodominant V3-directed non-neutralizing response to HIV-1 envelope trimers
por: de Taeye, Steven W., et al.
Publicado: (2018)

Development and evaluation of a four-tube real time multiplex PCR assay covering fourteen respiratory viruses, and comparison to its corresponding single target counterparts
por: Jansen, Rogier R., et al.
Publicado: (2011)

HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds
por: van den Kerkhof, Tom L. G. M., et al.
Publicado: (2016)

Stabilized HIV-1 envelope glycoprotein trimers for vaccine use
por: Medina-Ramírez, Max, et al.
Publicado: (2017)

Strategies for inducing effective neutralizing antibody responses against HIV-1
por: del Moral-Sánchez, Iván, et al.
Publicado: (2019)

Envelope Glycoprotein of Arenaviruses
por: Burri, Dominique J., et al.
Publicado: (2012)

Presentation of HIV-1 envelope glycoprotein trimers on diverse nanoparticle platforms
por: Brouwer, Philip J.M., et al.
Publicado: (2019)

Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs
por: Witt, Kristen C., et al.
Publicado: (2017)

Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
por: Torrents de la Peña, Alba, et al.
Publicado: (2018)

Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers
por: Sliepen, Kwinten, et al.
Publicado: (2021)

Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection
por: Brouwer, Philip J.M., et al.
Publicado: (2022)

Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike
por: Derking, Ronald, et al.
Publicado: (2021)

Author Correction: Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers
por: Sliepen, Kwinten, et al.
Publicado: (2021)

HIV-1 envelope characteristics that coincide with the development of cross-reactive neutralizing activity in HIV-1 infected patients
por: van den Kerkhof, Tom, et al.
Publicado: (2011)

Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses
por: Brinkkemper, Mitch, et al.
Publicado: (2022)

Febrile neutropenia: significance of elaborated screening for respiratory viruses, and the comparison of different sampling methods, in neutropenic patients with hematological malignancies
por: Jansen, Rogier R, et al.
Publicado: (2013)

Membrane Glycoproteins of Enveloped Viruses
por: Compans, Richard W., et al.
Publicado: (1978)

Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C
por: Klasse, P. J., et al.
Publicado: (2016)

Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques
por: Klasse, P. J., et al.
Publicado: (2018)

Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization
por: Torrents de la Peña, Alba, et al.
Publicado: (2017)

Stable HIV-1 envelope glycoprotein immune complexes as vaccine immunogens
por: van Montfort, Thijs, et al.
Publicado: (2011)

Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer
por: Derking, Ronald, et al.
Publicado: (2015)

Stabilization of the V2 loop improves the presentation of V2 loop–associated broadly neutralizing antibody epitopes on HIV-1 envelope trimers
por: de Taeye, Steven W., et al.
Publicado: (2019)

Characterization of retrovirus-based reporter viruses pseudotyped with the precursor membrane and envelope glycoproteins of four serotypes of dengue viruses
por: Hu, Hsien-Ping, et al.
Publicado: (2007)

High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimers
por: del Moral-Sánchez, Iván, et al.
Publicado: (2022)

Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo
por: Medina-Ramírez, Max, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t3u3mtvkkmktidmsdkjs3ftcvf